(INVS_COMD)Number of HIV program related commodities purchased and dollars spent in the last 12 months

Export Indicator

Number of HIV program related commodities purchased and dollars spent in the last 12 months
What it measures

To better understand PEPFAR’s financial investments in commodities and overall commodities contribution to host national programs

Numerator

PEPFAR resources used for HIV-program related commodities: number of commodities purchased and dollars spent in the last 12 months by Implementing Partner

Denominator

N/A

Calculation

The total dollar amount spent and absolute number of select commodities purchased during the previous 12 month reporting period (regardless of whether commodities have presently been delivered to the country program).

Expenditures should be reported using the same framework as PEPFAR Expenditure Analysis. Additional details in the Alignment and relationship to PEPFAR Expenditure Analysis section.

Method of measurement

The PEPFAR dollar amount spent and absolute number of commodities purchased should be completed by every implementing partner (IP) that purchases PEPFAR- funded commodities as listed below:

- Number of HIV Rapid Diagnostic test KITS purchased;

o Dollars spent on the purchase of HIV test kits, including HIV rapid test kits, but not EID (see below)

- HIV CD4 reagents purchased (number of tests that can be done with the reagents) Dollar spent on the purchase of CD4 reagents

- HIV viral load reagents purchased (including EID testing); number of tests that can be done with the reagents; Dollar spent on the purchase of VL reagents.

- First-line HIV ARVs

o Including first-line National recommendations for the treatment of pediatric and adult patients.

o Dollars spent on the purchase of first line ARVs.

- Second-line ARVS

o Including second-line National recommendations for the treatment of pediatric and adult patients.

o Dollars spent on the purchase of second line ARVs.

- Number of condoms purchased and dollars spent.

How to review for data quality:

Compare to national investment, COP document commitment and Q4 results for testing, viral load testing, patients newly and currently enrolled on ART for triangulation. Triangulate with EA data for unit expenditure investments

Reporting Level

IM OU level

Measurement frequency

Q4 data should be collected for this indicator.

Disaggregation

Numerator (required): Number of HIV program related commodities purchased and dollars spent in the last 12 months by Implementing Partner

USD (with current exchange rate) (required)

Number (required)

Commodity Type [Dollars planned/spent HIV Rapid Diagnostic test KITS; Dollars planned/spent HIV CD4; Dollars planned/spent HIV viral load; Dollars planned/spent condoms; Dollars planned/spent HIV ARV]

Commodity Type [HIV Rapid Diagnostic test KITS; HIV CD4 reagents; condoms, HIV viral load reagents; First-line HIV ARVs and Second-line HIV ARVs]

Description of Disaggregate

HIV test KITS; HIV CD4 reagents; HIV viral load reagents (including EID testing); Condoms, Firstline HIV ARVs, Second line HIV ARVs for pediatric and adults).

Absolute number of each commodity purchased, as costs can vary by country

Denominator: N/A

Further information

PEPFAR Support definition

None

DREAMS SNU Specific Guidance

None

Alignment and relationship to PEPFAR

Amount purchased and dollars spent should be reported using the same framework as PEPFAR Expenditure Analysis. Only PEPFAR expenditures should be reported. More specifically, this indicator should report any PEPFAR expenditures from eligible sources

Expenditure Analysis

(COP funded expenditures plus those funded by central funds that support site-level targets that are not programmed through COP/ROP including TB/HIV funds, Key Population Challenge Fund, PMTCT Acceleration, Rapid Test Kit Reserves, VMMC reserves, Contraceptive fund, ACT and DREAMS).

Dollars spent during the last fiscal year should be reported using a cash based of accounting and “financial expenditures” would be defined as cash disbursements from the perspective of the prime contractor or awardee.

Please note: Only select commodities will be reported through MER, the total spending across MER and EA will not match (EA is comprehensive of all eligible expenditures within the last fiscal year)

The total spent reported for the following disaggregates should match exactly with totals reported into the analogous EA cost categories (summed across EA program areas): HIV Test Kits, Condoms, ARVs